Table 4.
FI-Lab21 at admission to hospital (FI-Lab21admission), FI-Lab21 before discharge from hospital (FI-Lab21discharge), and the change of the FI-Lab21 during the hospital stay (∆FI-Lab21) stratified according to score with 6-month and 1-year mortality
| FI-Lab21 score | All patients, % (n=494) | Six-month mortality, % (n=86) | P-value | One-year mortality, % (n=114) | P-value |
|---|---|---|---|---|---|
| FI-Lab21admission | <0.001 | <0.001 | |||
| 0 | 0.0 (n=2) | 0.0 (n=0) | 0.0 (n=0) | ||
| 0.001–0.1 | 6.3 (n=31) | 0.0 (n=0) | 0.0 (n=0) | ||
| 0.101–0.2 | 15.8 (n=78) | 10.3 (n=8) | 12.8 (n=10) | ||
| 0.201–0.3 | 22.1 (n=109) | 6.4 (n=7) | 11.0 (n=12) | ||
| 0.301–0.4 | 23.5 (n=116) | 16.8 (n=20) | 23.3 (n=27) | ||
| 0.401–0.5 | 18.2 (n=90) | 26.1 (n=24) | 35.6 (n=32) | ||
| >0.5 | 13.8 (n=68) | 39.7 (n=27) | 48.5 (n=33) | ||
| FI-Lab21discharge | <0.001 | <0.001 | |||
| 0 | 1.4 (n=7) | 0.0 (n=0) | 14.7 (n=1) | ||
| 0.001–0.1 | 6.9 (n=34) | 0.0 (n=0) | 0.0 (n=0) | ||
| 0.101–0.2 | 16.2 (n=80) | 4.9 (n=4) | 7.5 (n=6) | ||
| 0.201–0.3 | 24.9 (n=123) | 11.4 (n=14) | 17.9 (n=22) | ||
| 0.301–0.4 | 23.9 (n=118) | 15.6 (n=19) | 19.5 (n=23) | ||
| 0.401–0.5 | 19.2 (n=95) | 30.2 (n=29) | 38.9 (n=37) | ||
| >0.5 | 7.5 (n=37) | 54.1 (n=20) | 67.6 (n=25) | ||
| ∆FI-Lab21 | 0.004 | 0.046 | |||
| ≥0 | 67.0 (n=331) | 13.9 (n=47) | 20.8 (n=69) | ||
| <0 | 33 (n=163) | 23.9 (n=39) | 27.6 (n=45) |
Note: ∆FI-Lab21= FI-Lab21admission – FI-Lab21discharge.
Abbreviations: FI-Lab21, 21-item frailty index based on laboratory blood and urine tests; FI-Lab21admission, frailty index obtained at admission to hospital; FI-Lab21discharge, frailty index obtained before discharge from hospital.